Business Wire

CA-NOMINAL

22.4.2024 19:29:30 CEST | Business Wire | Press release

Share
Nominal Emerges From Stealth With Backing From General Catalyst, Lux Capital, Founders Fund, for Navigating Mission-Critical Data Analytics

Nominal, a company specializing in creating end-to-end data analysis solutions for industrial engineering teams, emerged from stealth to provide a faster, more reliable way to review test data and validate mission-critical systems. The startup raised $7.5M in Seed funding led by Lux Capital with support from Founders Fund and $20M in their Series A led by General Catalyst. Additional investors include Haystack VC, XYZ Ventures, Human Capital, Box Group, and Overmatch.

Nominal specializes in creating software solutions for the Aerospace, Defense, Industrial Machinery, Transportation, and Energy sectors with various partnerships across the U.S. government. The company is led by co-founder and CEO Cameron McCord, who has extensive experience in the private sector at prominent startups Anduril, Applied Intuition, and Saildrone and as a venture capitalist, and in the public sector as a veteran Nuclear Submarine Officer and Congressional Liaison for the Navy. McCord works closely with his co-founders Bryce Strauss, a former Lockheed Martin Space division systems engineer who worked on inter-planetary robotic missions and building software tools for engineers, and Jason Hoch, an experienced software engineer who has diverse experience creating data products for startups, Fortune 500 companies, and governments.

Nominal's platform is designed to handle sensitive government and industrial data. The company's leadership team brings over 15 years of combined experience in both hardware and software from organizations like SpaceX, Palantir, Anduril, Applied Intuition, NASA, Microsoft, and more.

“Building trust in industrial systems and the data that these systems generate is core to our mission at Nominal. As aerospace, defense, and industrial systems have rapidly become more complex and software-defined, the software tools and infrastructure that engineers and operators use to make sense of and validate these systems have lagged in a costly and dangerous way.” Cameron McCord, Co-founder and CEO of Nominal said, “We’re choosing now to come out of stealth because we feel ready to accelerate our mission to help engineers that develop, test, and validate mission-critical industrial systems. We are on an industrial software collision course. Time is ticking - for our commercial customers, this means getting a product safely to market faster, and for our government customers, it means fielding reliable and tested systems for any mission.”

With Nominal, teams can quickly test and deploy their complex hardware systems. Nominal is dedicated to providing a robust, end-to-end solution that simplifies workflows, fosters collaboration, and seamlessly scales with the evolving needs of its valued customers and partners. Nominal also enables teams and organizational-level collaboration and visibility to reflect the multidisciplinary and iterative nature of engineering. The more people in an engineering organization who can view a comprehensive data story, the better the understanding and insights gained.

"When we first met Nominal, what stood out to us was the intentionality by which Cameron, Bryce, and Jason are building the company. Nominal’s modern software suite is purpose-built for hardware engineers to manage the complex workflows of testing and developing high-stakes, breakthrough hardware systems. By hitting the industrial software collision course head-on, we believe Nominal can help unlock a renaissance of industrial innovation,” said Paul Kwan, Managing Partner, General Catalyst.

Nominal is utilizing this latest infusion of capital to uphold its commitment to delivering innovative solutions to the defense and aerospace sectors, including the rollout of its full-stack data analysis solution designed to facilitate and expedite the process of analyzing and reviewing test data for engineering teams. Beyond new product initiatives to meet growing customer demands, the company also intends to grow its teams and enhance its security and deployment capabilities.

About Nominal

Nominal is igniting the next industrial revolution. By allowing for rapid and accurate review of test data and the validation of critical systems through its comprehensive data analysis platform, Nominal provides modern workflows specifically tailored to the needs of engineering teams that develop, validate, and monitor hardware. At Nominal, we believe hardware engineers deserve the world’s best software. We are fully committed to helping our users more efficiently and effectively test and deploy mission-critical systems that will change the world. Nominal currently supports mission-critical data analysis and testing at companies across the aerospace, defense, energy, and industrial spheres including Varda Space, Muon Space, REGENT, Radiant Nuclear, the U.S. Air Force, and others. We are supported by leading venture investors such as General Catalyst, Lux Capital, Founders Fund, Haystack, XYZ Ventures, Human Capital, BoxGroup, and Overmatch. To learn more about Nominal and its innovative solutions, please visit nominal.io.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240418799842/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Plasma One Launches to Herald a New Era of Stablecoin Banking19.6.2026 14:29:00 CEST | Press release

Plasma has today announced the launch of Plasma One, its flagship financial product designed to make digital dollars usable for everyday spending, sending and earning. Plasma One is designed to make stablecoins feel like money, only better - more accessible, reliable and efficient. For years, stablecoin adoption has been held back by a fragmented system and poor user experience. We have seen wallets in one place, exchanges in another, and costly off-ramps standing between digital dollars and daily life. Plasma One brings that experience together in a single app, giving users a simple way to spend, send and earn with stablecoins from one account with zero fees. Headquartered in London, the city that gave rise to Revolut, Wise and Monzo, Plasma is making a bigger bet, that the next generation of consumer banking will be built on stablecoin rails, not legacy banking infrastructure. Underneath Plasma One is the Plasma Network, Plasma’s own blockchain, purpose-built to move stablecoins inst

IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 09:00:00 CEST | Press release

Ciesla is a seasoned deep tech executive with more than 25 years of experience delivering products across industries — from startups to Fortune 500 companies. De Vega brings more than 20 years of experience advancing quantum technologies from fundamental research to intellectual property and industrial applications. IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced d

Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 09:00:00 CEST | Press release

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)19.6.2026 08:00:00 CEST | Press release

Incyte Biosciences Japan G.K. today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Minjuvi® (tafasitamab) in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). “This approval provides a new option for patients in Japan living with relapsed or refractory DLBCL, an aggressive disease with historically limited treatment options,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “We are committed to helping address critical unmet needs for patients and their families affected by this challenging cancer.” DLBCL is the most common subtype of non-Hodgkin lymphoma and is an aggressive malignancy of B lymphocytes. While many patients respond to initial therapy, outcomes remain poor for those with relapsed or refractory disease, particularly for patients who are not eligible for autologous stem cell transplant.1 The approval is based on results from the MOR208C203 Trial: L

Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training18.6.2026 19:07:00 CEST | Press release

New multi-sensor system captures heart rate, movement quality, stability and muscle load to provide a more complete view of performance under fatigue Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), today announced Helio Strap Pro, a body-worn training system designed to help HYROX and hybrid athletes better understand how their bodies perform under load. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618031434/en/ Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training Building on the screen-free Helio Strap, Helio Strap Pro adds a dedicated waist-mounted motion sensor that captures core-body movement and stability during training. Combined with upper-arm heart-rate sensing and compatible Amazfit smartwatches, the system provides a more complete picture of cardio effort, movement quality and muscle load than wrist-based tracking alone. Hel

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye